Vibativ

RSS

Withdrawn

This medicine's authorisation has been withdrawn

telavancin
MedicineHumanWithdrawn

Maltese is available via eTranslation, the European Commission's machine translation service.

Translate to Maltese | Important information about machine translation

  • Application under evaluation
  • CHMP opinion
  • European Commission decision

Overview

The marketing authorisation for Vibativ has been withdrawn at the request of the marketing authorisation holder.

български (BG) (634.53 KB - PDF)

Ara

español (ES) (549.37 KB - PDF)

Ara

čeština (CS) (617.26 KB - PDF)

Ara

dansk (DA) (547.17 KB - PDF)

Ara

Deutsch (DE) (552 KB - PDF)

Ara

eesti (ET) (546.46 KB - PDF)

Ara

ελληνικά (EL) (639.48 KB - PDF)

Ara

français (FR) (550.8 KB - PDF)

Ara

hrvatski (HR) (1.06 MB - PDF)

Ara

italiano (IT) (548.98 KB - PDF)

Ara

latviešu (LV) (616.63 KB - PDF)

Ara

lietuvių (LT) (577.48 KB - PDF)

Ara

magyar (HU) (610.46 KB - PDF)

Ara

Malti (MT) (620.67 KB - PDF)

Ara

Nederlands (NL) (547.6 KB - PDF)

Ara

polski (PL) (615.07 KB - PDF)

Ara

português (PT) (549.16 KB - PDF)

Ara

română (RO) (576.09 KB - PDF)

Ara

slovenčina (SK) (617.05 KB - PDF)

Ara

slovenščina (SL) (568.91 KB - PDF)

Ara

suomi (FI) (547.15 KB - PDF)

Ara

svenska (SV) (548.33 KB - PDF)

Ara

Product information

български (BG) (1.66 MB - PDF)

Ara

español (ES) (972.49 KB - PDF)

Ara

čeština (CS) (1.37 MB - PDF)

Ara

dansk (DA) (998.7 KB - PDF)

Ara

Deutsch (DE) (1012.89 KB - PDF)

Ara

eesti (ET) (990.29 KB - PDF)

Ara

ελληνικά (EL) (1.7 MB - PDF)

Ara

français (FR) (1.03 MB - PDF)

Ara

hrvatski (HR) (1014.8 KB - PDF)

Ara

italiano (IT) (1.03 MB - PDF)

Ara

latviešu (LV) (1.41 MB - PDF)

Ara

lietuvių (LT) (1023.66 KB - PDF)

Ara

magyar (HU) (1.37 MB - PDF)

Ara

Malti (MT) (1.44 MB - PDF)

Ara

Nederlands (NL) (1016.54 KB - PDF)

Ara

polski (PL) (1.45 MB - PDF)

Ara

português (PT) (1004.82 KB - PDF)

Ara

română (RO) (1.06 MB - PDF)

Ara

slovenčina (SK) (1.39 MB - PDF)

Ara

slovenščina (SL) (1.39 MB - PDF)

Ara

suomi (FI) (983.01 KB - PDF)

Ara

svenska (SV) (1002.26 KB - PDF)

Ara

Íslenska (IS) (985.54 KB - PDF)

Ara

norsk (NO) (343.48 KB - PDF)

Ara
Latest procedure affecting product information:IAIN/0031
08/09/2017
icon globe

This medicine’s product information is available in all official EU languages.
Select 'available languages' to access the language you need.

 

Product information documents contain:

  • summary of product characteristics (annex I);
  • manufacturing authorisation holder responsible for batch release (annex IIA);
  • conditions of the marketing authorisation (annex IIB);
  • labelling (annex IIIA);
  • package leaflet (annex IIIB).

български (BG) (529.08 KB - PDF)

Ara

español (ES) (485.69 KB - PDF)

Ara

čeština (CS) (529.3 KB - PDF)

Ara

dansk (DA) (485.73 KB - PDF)

Ara

Deutsch (DE) (484.5 KB - PDF)

Ara

eesti (ET) (485.88 KB - PDF)

Ara

ελληνικά (EL) (528.76 KB - PDF)

Ara

français (FR) (484.57 KB - PDF)

Ara

hrvatski (HR) (492.6 KB - PDF)

Ara

italiano (IT) (503.04 KB - PDF)

Ara

latviešu (LV) (526.53 KB - PDF)

Ara

lietuvių (LT) (502.59 KB - PDF)

Ara

magyar (HU) (508.09 KB - PDF)

Ara

Malti (MT) (522.89 KB - PDF)

Ara

Nederlands (NL) (485.68 KB - PDF)

Ara

polski (PL) (523.08 KB - PDF)

Ara

português (PT) (485.04 KB - PDF)

Ara

română (RO) (509.16 KB - PDF)

Ara

slovenčina (SK) (540.33 KB - PDF)

Ara

slovenščina (SL) (507.44 KB - PDF)

Ara

suomi (FI) (488.95 KB - PDF)

Ara

svenska (SV) (485.59 KB - PDF)

Ara

Íslenska (IS) (484.25 KB - PDF)

Ara

norsk (NO) (469.96 KB - PDF)

Ara

български (BG) (700.28 KB - PDF)

Ara

español (ES) (613.31 KB - PDF)

Ara

čeština (CS) (1.19 MB - PDF)

Ara

dansk (DA) (614.54 KB - PDF)

Ara

Deutsch (DE) (617.65 KB - PDF)

Ara

eesti (ET) (617.52 KB - PDF)

Ara

ελληνικά (EL) (697.34 KB - PDF)

Ara

français (FR) (618.22 KB - PDF)

Ara

italiano (IT) (619.69 KB - PDF)

Ara

latviešu (LV) (660.48 KB - PDF)

Ara

lietuvių (LT) (634.24 KB - PDF)

Ara

magyar (HU) (647.41 KB - PDF)

Ara

Malti (MT) (768.5 KB - PDF)

Ara

Nederlands (NL) (613.46 KB - PDF)

Ara

polski (PL) (699.38 KB - PDF)

Ara

português (PT) (625.07 KB - PDF)

Ara

română (RO) (643.04 KB - PDF)

Ara

slovenčina (SK) (679.65 KB - PDF)

Ara

slovenščina (SL) (744.22 KB - PDF)

Ara

suomi (FI) (606.41 KB - PDF)

Ara

svenska (SV) (612 KB - PDF)

Ara

Product details

Name of medicine
Vibativ
Active substance
telavancin
International non-proprietary name (INN) or common name
telavancin
Therapeutic area (MeSH)
  • Pneumonia, Bacterial
  • Cross Infection
Anatomical therapeutic chemical (ATC) code
J01XA03

Pharmacotherapeutic group

Antibacterials for systemic use

Therapeutic indication

Vibativ is indicated for the treatment of adults with nosocomial pneumonia including ventilator-associated pneumonia, known or suspected to be caused by methicillin-resistant Staphylococcus aureus (MRSA).

Vibativ should be used only in situations where it is known or suspected that other alternatives are not suitable.

Consideration should be given to official guidance on the appropriate use of antibacterial agents.

Authorisation details

EMA product number
EMEA/H/C/001240
Marketing authorisation holder
Theravance Biopharma Ireland Umited

Connaught House 1
Burlington Road
Fourth Floor
D04 C5Y6
Dublin 4
Ireland

Marketing authorisation issued
02/09/2011
Revision
10

Assessment history

This page was last updated on

Share this page